We could not find any results for:
Make sure your spelling is correct or try broadening your search.
L'OCRCVM permet la reprise de la négociation - NPTH Canada NewsWire VANCOUVER, BC, le 20 oct. 2020 VANCOUVER, BC, le 20 oct. 2020 /CNW/ - Reprise des négociations pour : Société :...
IIROC Trading Resumption - NPTH Canada NewsWire VANCOUVER, BC, Oct. 20, 2020 VANCOUVER, BC, Oct. 20, 2020 /CNW/ - Trading resumes in: Company: Neupath Health Inc. TSX-Venture Symbol: NPTH All...
NeuPath Health Inc. Announces Increase to Bought Deal Financing to $10.4 Million Canada NewsWire TORONTO, Oct. 20, 2020 /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE...
Suspension de la négociation par l'OCRCVM - NPTH Canada NewsWire VANCOUVER, BC, le 19 oct. 2020 VANCOUVER, BC, le 19 oct. 2020 /CNW/ - L'OCRCVM a suspendu la négociation des titres...
IIROC Trading Halt - NPTH Canada NewsWire VANCOUVER, BC, Oct. 19, 2020 VANCOUVER, BC, Oct. 19, 2020 /CNW/ - The following issues have been halted by IIROC: Company: Neupath Health...
NeuPath Health Inc. Announces $8 Million Bought Deal Offering of Units Canada NewsWire TORONTO, Oct. 19, 2020 /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED...
TMX Group, NeuPath, C-Suite at The Open Canada NewsWire TORONTO, Aug. 31, 2020 TORONTO, Aug. 31, 2020 /CNW/ - Grant Connelly, CEO, NeuPath Health Inc. (TSXV: NPTH), shares his company's story...
NeuPath Health Inc. Virtually Opens The Market Canada NewsWire TORONTO, July 20, 2020 TORONTO, July 20, 2020 /CNW/ - Brady Fletcher, Head of TSX Venture Exchange joined Grant Connelly, Chief...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions